PUBLIC CONTRACT · 2019
Infliximab 100 mg (biossimilar) pó conc sol inj fr IV
- Contract value
- €42,900.00
- Signed on
- 20 February 2019
- Procedure
- Ao abrigo de acordo-quadro (art.º 259.º)
This page lays out the fields published on Portal BASE and says when a field is unavailable. It is not an assessment of the contract's merit, legality or impact.
Record 5310522PUBLISHED SUBJECT
INFLIXIMAB 100 MG (BIOSSIMILAR) PÓ CONC SOL INJ FR IV
WHO CONTRACTED
Parties involved
- Place of performance
- Portugal, Setúbal, Almada
- NUTS region
- Not stated
WHO BID
Awardee and competitors
Companies that IMPIC lists as the awardee and as competitors in this procedure.
- Awardee
- PHARMAKERN PORTUGAL, Produtos Farmacêuticos Soc. Unipessoal Lda · Tax ID 507002571
HOW MUCH AND WHEN
Values and timeline
- Contract price
- €42,900.00
- Procedure base price
- €42,900.00
- Total effective price
- Not reported on Portal BASE
- Publication date
- 6 March 2019
- Award date
- 20 February 2019
- Signing date
- 20 February 2019
- Performance period
- 30 days
The contract price is the value agreed in the contract, not the amount paid.
HOW IT WAS CONTRACTED
Procedure and framework
- Contract type
- Aquisição de bens móveis
- Procedure type
- Ao abrigo de acordo-quadro (art.º 259.º)
- Award criterion
- Preço ou custo
- CPV code
- 33600000-6 - Produtos farmacêuticos
- Legal basis
- Artigo 259.º do Código dos Contratos Públicos
- Regime
- Código dos Contratos Públicos ( DL 111-B/2017 )
- Framework agreement
- CP 2017/6 - Acordo Quadro para fornecimento de Medicamentos do Foro Oncológico e Imunomoduladores, às Instituições e Serviços do Serviço Nacional de Saúde
- Centralised procedure
- No
- Environmental criterion
- No
- Notice
- Not stated
- Procedure identifier
- 3882956
KEEP EXPLORING
Compare with other contracts
Search the same body, supplier, place or type of service to understand the context of the published index.